AC
ELV icon

ASB Consultores’s Elevance Health ELV Stock Holding History

ASB Consultores’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-722
Closed -$281K – 66
2025
Q2 		$281K Buy
722
+198
+38% +$79.6K 0.19% 94
2025
Q1 		$228K Buy
+524
New +$210K 0.15% 99
2024
Q4 		– Sell
-765
Closed -$398K – 218
2024
Q3 		$398K Buy
765
+208
+37% +$111K 0.16% 102
2024
Q2 		$302K Sell
557
-92
-14% -$48.6K 0.11% 135
2024
Q1 		$337K Buy
+649
New +$323K 0.09% 183
2023
Q1 		– Sell
-818
Closed -$420K – 198
2022
Q4 		$420K Buy
818
+86
+12% +$43.7K 0.17% 88
2022
Q3 		$333K Hold
732
– – 0.16% 105
2022
Q2 		$353K Buy
732
+15
+2% +$7.42K 0.15% 91
2022
Q1 		$352K Buy
717
+219
+44% +$100K 0.15% 128
2021
Q4 		$231K Buy
+498
New +$210K 0.11% 199

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

ASB Consultores's ELV Position: Q3 2025 in Review

ASB Consultores sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 722 shares — an estimated $281K sold.

ASB Consultores first reported a position in ELV in Q4 2021 and held it in 10 quarters. The position peaked at $420K in Q4 2022. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • ASB Consultores reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • ASB Consultores sold 722 Elevance Health shares in Q3 2025, an estimated $281K.
  • ASB Consultores first reported a position in Elevance Health in Q4 2021 and held it in 10 quarters.
  • ASB Consultores's Elevance Health position peaked at $420K in Q4 2022.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on ASB Consultores's 13F filing for Q3 2025, filed 4 Nov 2025.